That said, this newer biotech player could eventually carve out ... as this year -- but something else this year could boost the stock price -- promising clinical-trial data.

Harmony Biosciences’ (HRMY) recently released growth plans and pipeline advancements have showcased the company’s dedication ...

Shares of Gilead Sciences ( GILD -1.77%) were jumping 7.9% higher on Wednesday at 11:34 a.m. The solid gain came after the ...

We used the Finviz stock screener to compile a list of 40 biotech stocks. We then selected the top 12 stocks with the highest analyst upside potential as of January 15, 2025.

And despite major regulatory wins since late 2023, the biotech hasn't recovered: The stock is down 23% year to date. Can CRISPR Therapeutics bounce back? Some recent developments could move the ...

Improving Trends for Biotech Stocks While 2024 was a “challenging” year for biotech stocks, JPMorgan […] We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential.

Our analyst team just revealed what they believe are the 10 best stocks to buy right now ... That said, this newer biotech player could eventually carve out a spot if all continues to go well ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a look at where Ardelyx, Inc. (NASDAQ:ARDX) stands against the other best ...

The improved sales of Nerlynx have been the primary reason for the stock’s increase during the said time. Puma Biotechnology in-licensed global development and commercialization rights for ...